Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A
Clinical trial NCT04046848 · TERMINATED
Trial details
- NCT number
- NCT04046848
- Sponsor
- Octapharma
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2022-02-18
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.